How to investigate levels of Adherence to antiretroviral ... - INRUD

More documents

Recommendations

Info

Chapter 5 Data collection tools and how to modify, print and fill them in Some comments about workflow The system will support the entry of data using a variety of different sequences. The aim of the exercise is to complete the double-entry of three different forms. Here are some examples to illustrate this. Sequence number Step Example 1: 1 First Entry Facility Questionnaire 2 First Entry Retrospective Dispensing Data 3 First Entry Exit Interviews 4 Second Entry Facility Questionnaire 5 Second Entry Retrospective Dispensing Data 6 Second Entry Exit Interviews Example 2: 1 First Entry Facility Questionnaire 2 Second Entry Facility Questionnaire 3 First Entry Retrospective Dispensing Data 4 Second Entry Retrospective Dispensing Data 5 First Entry Exit Interviews 6 Second Entry Exit Interviews Example 3: 1 First Entry Facility Questionnaire 2 First Entry Exit Interviews – commencement of 3 First Entry Retrospective Dispensing Data – commencement of 4 Second Entry Facility Questionnaire 5 First Entry Retrospective Dispensing Data – completion of 6 Second Entry Retrospective Dispensing Data 7 First Entry Exit Interviews – completion of 8 Second Entry Exit Interviews Second data entry The data entered for the first and second data entry are the same. There are some minor differences between the two sets of functions. This includes the comparison of data entered into the second data set being compared to the first data set entered. There are also some differences relating to summary fields. These are discussed in more detail in Chapter 8. Consolidation Description of the procedures to consolidate the entered data into a summary report are included in the Data Consolidation Section, Chapter 8. 59
6 CHAPTER 6 --- Planning and field methods Preparations for survey Surveys are most useful when they are designed to meet specific objectives. Managers and policy-makers responsible for administering an HIV/AIDS programme, or health providers responsible for supervising the quality of medical care in public sector ART facilities would be interested in the results of an adherence indicator survey. If the initiative for carrying out an adherence survey does not originate with such people, they should be involved in its design at an early stage. Adequate planning and preparation for the survey will increase the likelihood that data will be collected and recorded in a reliable way. Persons planning and carrying out an adherence indicators survey need a basic knowledge of pharmaceuticals, some understanding of the principles of sample surveys, and an appreciation of the logistical requirements for carrying out field studies. The indicators and methods recommended in this manual have been designed to minimize as far as possible the need for a high level of sophistication in these areas. Carrying out more in-depth follow-up activities, or designing and mounting an intervention, will in many cases require a higher level of technical expertise. Permissions and approval Often this work will be carried out by or for the National AIDS Control Programme. If this is the case, they may not need any outside permission. If such a survey is being carried out by any other group, they will need letter of permission from the National Aids Control Programme documenting their approval. In addition, the survey group may need approval from an ethical review board. This will depend on the country. Select and prepare sample sites Issues involved in the selection of an appropriate sample of facilities have been addressed in Chapter 4. Once facilities have been selected and staff trained, the field work can begin. One key to the success of a study is adequate preparation of sample sites. Preparation includes adequate notification to relevant authorities of the study’s purposes and methods. This increases the likelihood that the study results will be accepted and 60
Page 1 and 2:
WHO/EMP/MIE/2011.1 How to Investiga
Page 3 and 4:
How to Investigate Adherence to Ant
Page 5 and 6:
Page 7 and 8:
CONTENTS Acknowledgements .........
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18: How to Investigate Adherence to Ant
Page 67: How to Investigate Adherence to Ant
Page 119 and 120:
Page 121 and 122:
A.3 APPENDIX 3 --- Training slides
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
A.4 APPENDIX 4 --- Report template
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157:
show all

How to investigate levels of Adherence to antiretroviral ... - INRUD

Create successful ePaper yourself

Delete template?

Save as template?